The Clinical Efficacy of Midline Catheters for Intravenous Therapy: a Randomized, Controlled Study
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 120
- 试验地点
- 2
- 主要终点
- Reducing the use of CVC and PVC
研究概览
简要总结
The study will evaluate the clinical efficacy of midline catheters compared to conventional treatment in patients with an expected intravenous therapy duration of more than 5 days. Patients will be randomized in a 1:1 ratio. The study will include 120 patient. Endpoints include insertion of CVSs, peripheral venous catheters, catheter patency and a number of possible complications.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Other
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 —(Adult, Older Adult)
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Admission to the Department of Infectious Disease or Department of Heart Disease.
- •≥18 years of age
- •Expected requirement for iv. therapy >5 days from the day of enrolment as evaluated by a specialist in infectious diseases.
- •Mentally competency
排除标准
- •Lack of patient consent
- •Requirement for a CVC before study eligibility screening or anticipation of an absolute indication for CVC inserted within 24 hours of screening
- •Personnel for insertion of midline catheter not available
结局指标
主要结局
Reducing the use of CVC and PVC
时间窗: through study completion, an average of 7 month
The fraction of patients requiring either a CVC - including PICC line - or require ≥ 4PVC insertions during the current admittance to the hospital, including follow-up intravenous therapy.
次要结局
- Patient satisfaction(through study completion, an average of 7 month)
- Rescue catherizations 2(through study completion, an average of 7 month)
- Time consumption(through study completion, an average of 7 month)
- Thrombosis 3(through study completion, an average of 7 month)
- Catheter discontinuation(through study completion, an average of 7 month)
- Problems with catheter bloodsampling(through study completion, an average of 7 month)
- Nurse satisfaction(through study completion, an average of 7 month)
- Bloodsamples from catheter(through study completion, an average of 7 month)
- Catheter related infections(through study completion, an average of 7 month)
- Thrombosis 4(through study completion, an average of 7 month)
- Bloodsamples (conventional)(through study completion, an average of 7 month)
- Fluid(through study completion, an average of 7 month)
- Treatment type(through study completion, an average of 7 month)
- Painscore(through study completion, an average of 7 month)
- Thrombosis 1(through study completion, an average of 7 month)
- Insertion complication 2(through study completion, an average of 7 month)
- Rescue catherizations 1(through study completion, an average of 7 month)
- Catheter dwelltime(through study completion, an average of 7 month)
- Treatment amount(through study completion, an average of 7 month)
- Thrombosis 2(through study completion, an average of 7 month)
- Insertion complication 3(through study completion, an average of 7 month)
- Neuropraxia(through study completion, an average of 7 month)
- Insertion complication(through study completion, an average of 7 month)
研究者
Emma Bundgaard Nielsen
Medical student, Research student
University of Aarhus
